The Aarskog Foundation
Michelle Erskine is the President & Group CEO at The Aarskog Foundation since February 2017. Michelle is also a Leadership Team member at Global Genes and served as Vice President and Exec Board Member at REMEMBER THE GIRLS INC. Michelle Erskine has experience as a Director at Indicium Uk Ltd and as a GIS Consultant at Serco Rail. Michelle has also worked as an LLPG Consultant at Generic Software Consultants and as a LLPG Custodian at Vale Royal Borough Council Cheshire. Additionally, Michelle Erskine has experience as a Land and Property Spatial Data Analyst at TMBC and as a Director at Rose Garden Recording Studios. Michelle also worked as a Direct Sales Support Manager at Scottish Equitable and held various positions at Agency Contracts.
This person is not in any teams
The Aarskog Foundation
The Aarskog Foundation is a global alliance of people living with Aarskog Syndrome (AS) of all nationalities. The Aarskog Foundation brings together Aarskog Syndrome patients from around the world to create a global alliance of patients and families faced with common challenges derived from the rarity of this RARE Genetic condition. Addressing Aarskog Syndrome is vital in order for it to be recognised as a disability across all governing bodies to ensure all Aarskog patients have access to the same resources as any other person. Patients living with Aarskog Syndrome come together through The Aarskog Foundation in a structured environment to create an Aarskog community and a voice through advocacy and exchange experiences. To this end we aim to unite, expand and put Aarskog Syndrome on the agenda of organisations and institutions both in the UK and across the world. We are a supportive Charity working to improve the quality of life for each individual Aarskog child and their families helping them to fulfil their potential educationally, to give ongoing support for Aarskog children who struggle receiving vital assessments and to educate others about some of the real difficulties faced growing up with the syndrome.